This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of combined aclidinium bromide and long-acting beta2-agonists in stable COPD.
CITATION STYLE
Ni, H., Moe, S., Soe, Z., Myint, K. T., & Viswanathan, K. N. (2015). Combined aclidinium bromide and long-acting beta2-agonist for COPD. Cochrane Database of Systematic Reviews, 2015(3). https://doi.org/10.1002/14651858.CD011594
Mendeley helps you to discover research relevant for your work.